GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ADC Therapeutics SA (NYSE:ADCT) » Definitions » Common Stock

ADCT (ADC Therapeutics) Common Stock : $8.43 Mil (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is ADC Therapeutics Common Stock?

ADC Therapeutics's quarterly common stock stayed the same from Jun. 2024 ($8.23 Mil) to Sep. 2024 ($8.23 Mil) but then increased from Sep. 2024 ($8.23 Mil) to Dec. 2024 ($8.43 Mil).

ADC Therapeutics's annual common stock stayed the same from Dec. 2022 ($7.31 Mil) to Dec. 2023 ($7.31 Mil) but then increased from Dec. 2023 ($7.31 Mil) to Dec. 2024 ($8.43 Mil).

ADC Therapeutics Common Stock Historical Data

The historical data trend for ADC Therapeutics's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ADC Therapeutics Common Stock Chart

ADC Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Common Stock
Get a 7-Day Free Trial Premium Member Only 6.31 6.45 7.31 7.31 8.43

ADC Therapeutics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.31 7.31 8.23 8.23 8.43

ADC Therapeutics Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

ADC Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ADC Therapeutics SA (NYSE:ADCT) » Definitions » Common Stock
Comparable Companies
NKTX PRQR SCPH HURA LRMR NKTR LXEO KOD GLSI ACTU VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
Route de la Corniche 3B, Biopole, Epalinges, CHE, 1066
Website
https://www.adctherapeutics.com
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.